HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroo Matsuoka Selected Research

Catatonic Schizophrenia

6/2007Resolution of catatonia by successful seizure induction via electroconvulsive therapy with electrodes applied bilaterally to the parietotemporal region.
8/2005Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
6/2003Short-term effect of ECT in middle-aged and elderly patients with intractable catatonic schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroo Matsuoka Research Topics

Disease

13Psychotic Disorders (Schizoaffective Disorder)
01/2019 - 10/2004
8Schizophrenia (Dementia Praecox)
09/2016 - 10/2004
4Catatonia
01/2009 - 01/2007
3Mental Disorders (Mental Disorder)
12/2008 - 06/2005
3Catatonic Schizophrenia
06/2007 - 06/2003
2Sleepiness
10/2015 - 11/2013
2Substance-Related Disorders (Drug Abuse)
09/2007 - 10/2004
2Seizures (Absence Seizure)
04/2006 - 03/2002
1Fasciculation (Fasciculations)
08/2011
1Neoplasms (Cancer)
07/2011
1Panic Disorder (Panic Attack)
06/2009
1Atrophy
01/2009
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2008
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
08/2008
1Pneumothorax
12/2007
1Addison Disease (Addison's Disease)
05/2007
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2007
1Epilepsy (Aura)
01/2007
1Major Affective Disorder 2
01/2007
1Parkinsonian Disorders (Parkinsonism)
01/2007
1Confusion (Bewilderment)
12/2005
1Depressive Disorder (Melancholia)
06/2005
1Alcohol-Related Disorders
06/2005
1Cognitive Dysfunction
01/2005
1Stomach Neoplasms (Stomach Cancer)
05/2003

Drug/Important Bio-Agent (IBA)

8Antipsychotic Agents (Antipsychotics)IBA
01/2019 - 01/2005
6Polytetrafluoroethylene (Teflon)FDA Link
01/2017 - 05/2009
4Pharmaceutical PreparationsIBA
10/2015 - 03/2002
3Proteins (Proteins, Gene)FDA Link
08/2013 - 01/2007
2BenzodiazepinesIBA
01/2009 - 12/2005
2Methamphetamine (Desoxyn)FDA LinkGeneric
09/2007 - 10/2004
1Biomarkers (Surrogate Marker)IBA
10/2018
1Mirtazapine (Rexer)FDA LinkGeneric
11/2013
1N 30IBA
06/2009
1Flumazenil (Romazicon)FDA LinkGeneric
06/2009
1AnticoagulantsIBA
12/2008
1A-factor (Streptomyces)IBA
08/2008
1Dopamine Agonists (Dopamine Agonist)IBA
09/2007
1SteroidsIBA
05/2007
1Immunoglobulins (Immunoglobulin)IBA
01/2007
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
01/2007
1Phenytoin (Dilantin)FDA LinkGeneric
04/2006
1LithiumIBA
12/2005
1Antidepressive Agents (Antidepressants)IBA
12/2005
1Paroxetine (Paxil)FDA LinkGeneric
12/2005
1Messenger RNA (mRNA)IBA
10/2004
1TeaIBA
05/2003
1Anticonvulsants (Antiepileptic Drugs)IBA
03/2002

Therapy/Procedure

3Therapeutics
12/2008 - 06/2003
1Aftercare (After-Treatment)
07/2011
1Fluid Therapy (Oral Rehydration Therapy)
12/2008
1Thoracostomy
12/2007
1Electrodes (Electrode)
06/2007
1Deinstitutionalization
07/2006
1Secondary Prevention
08/2005
1Activities of Daily Living (ADL)
06/2005